Dilafor
Solna
About Dilafor
Dilafor AB is a Swedish drug development company focusing on the development of tafoxiparin for obstetric indications. The company’s primary goal is to decrease the incidence of slow progress of labor both after induction of labor and after spontaneous onset of labor.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.9M
- Last round: Series Unknown (Sep 2016)
- Website: dilafor.com
- Phone: +46 70 790 02 07
Industries & Categories
Biopharma, Pharmaceutical
Canonical: https://fsome.com/organization/dilafor-40666 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.